Rapport Therapeutics, Inc. · NASDAQ:RAPP
Ignelzi Troy A. bought 5,500 Rapport Therapeutics, Inc. shares (Form 4)
Traded Oct 21, 2026 · Filed Oct 21, 2026
On Oct 21, 2026, Ignelzi Troy A. (Chief Financial Officer) bought 5,500 Rapport Therapeutics, Inc. shares at US$26.10 for US$144K, leaving 15,500 shares. Filed Oct 21, 2026 (Form 4).
- Bought
- 5,500 shares
- Price
- US$26.10
- Value
- US$144K
- Holding after
- 15,500 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Common Stock | Buy | 5,500 | US$26.10 | 15,500 | Direct |
Source
Download original · View original at SEC